BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24854378)

  • 1. Genetics of ANCA-associated vasculitides: HLA and beyond.
    Alberici F; Martorana D; Bonatti F; Gioffredi A; Lyons PA; Vaglio A
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S90-7. PubMed ID: 24854378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Alberici F; Martorana D; Vaglio A
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i37-45. PubMed ID: 25523449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct HLA and non-HLA associations in different subtypes of ANCA-associated vasculitides in North India.
    Singh J; Sharma A; Rani L; Kaur N; Anand S; Saikia B; Jha S; Nada R; Minz RW
    Int J Rheum Dis; 2020 Jul; 23(7):958-965. PubMed ID: 32297471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
    Merkel PA; Xie G; Monach PA; Ji X; Ciavatta DJ; Byun J; Pinder BD; Zhao A; Zhang J; Tadesse Y; Qian D; Weirauch M; Nair R; Tsoi A; Pagnoux C; Carette S; Chung S; Cuthbertson D; Davis JC; Dellaripa PF; Forbess L; Gewurz-Singer O; Hoffman GS; Khalidi N; Koening C; Langford CA; Mahr AD; McAlear C; Moreland L; Seo EP; Specks U; Spiera RF; Sreih A; St Clair EW; Stone JH; Ytterberg SR; Elder JT; Qu J; Ochi T; Hirano N; Edberg JC; Falk RJ; Amos CI; Siminovitch KA;
    Arthritis Rheumatol; 2017 May; 69(5):1054-1066. PubMed ID: 28029757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
    Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
    PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
    Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
    Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
    Chang DY; Li ZY; Chen M; Zhao MH
    Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the genomics of ANCA-associated vasculitis-a view from East Asia.
    Kawasaki A; Tsuchiya N
    Genes Immun; 2021 May; 22(1):1-11. PubMed ID: 33686257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically distinct subsets within ANCA-associated vasculitis.
    Lyons PA; Rayner TF; Trivedi S; Holle JU; Watts RA; Jayne DR; Baslund B; Brenchley P; Bruchfeld A; Chaudhry AN; Cohen Tervaert JW; Deloukas P; Feighery C; Gross WL; Guillevin L; Gunnarsson I; Harper L; Hrušková Z; Little MA; Martorana D; Neumann T; Ohlsson S; Padmanabhan S; Pusey CD; Salama AD; Sanders JS; Savage CO; Segelmark M; Stegeman CA; Tesař V; Vaglio A; Wieczorek S; Wilde B; Zwerina J; Rees AJ; Clayton DG; Smith KG
    N Engl J Med; 2012 Jul; 367(3):214-23. PubMed ID: 22808956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis.
    Li W; Huang H; Cai M; Yuan T; Sheng Y
    Front Immunol; 2021; 12():624848. PubMed ID: 33841406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population.
    Lundtoft C; Knight A; Meadows JRS; Karlsson Å; Rantapää-Dahlqvist S; Berglin E; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Eriksson P; Söderkvist P; Ronnblom L; Omdal R; Jonsson R; Lindblad-Toh K; Dahlqvist J
    RMD Open; 2024 Apr; 10(2):. PubMed ID: 38580345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics and pathophysiology of granulomatosis with polyangiitis (GPA) and its main autoantigen proteinase 3.
    Relle M; Föhr B; Fasola F; Schwarting A
    Mol Cell Probes; 2016 Dec; 30(6):366-373. PubMed ID: 27559009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in ANCA-associated vasculitis: a meta-analysis.
    Rahmattulla C; Mooyaart AL; van Hooven D; Schoones JW; Bruijn JA; Dekkers OM; ; Bajema IM
    Ann Rheum Dis; 2016 Sep; 75(9):1687-92. PubMed ID: 26443607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides.
    Borgmann S; Haubitz M
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S79-86. PubMed ID: 15675141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Cohort Study.
    Hilhorst M; Arndt F; Joseph Kemna M; Wieczorek S; Donner Y; Wilde B; Thomas Epplen J; van Paassen P; Cohen Tervaert JW
    Arthritis Rheumatol; 2016 Jul; 68(7):1721-30. PubMed ID: 26866715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of
    Kawasaki A; Sada KE; Kusumawati PA; Hirano F; Kobayashi S; Nagasaka K; Sugihara T; Ono N; Fujimoto T; Kusaoi M; Tamura N; Kusanagi Y; Itoh K; Sumida T; Yamagata K; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
    Front Immunol; 2023; 14():1119064. PubMed ID: 36969218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.
    Mahr A; Katsahian S; Varet H; Guillevin L; Hagen EC; Höglund P; Merkel PA; Pagnoux C; Rasmussen N; Westman K; Jayne DR;
    Ann Rheum Dis; 2013 Jun; 72(6):1003-10. PubMed ID: 22962314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.